Latest Posts

Stay in Touch With Us

Got a story worth telling? Send it our way. We read every tip that lands in our inbox.

Livebriefs

  /  All News   /  Eli Lilly targets alleged black market sales of its experimental GLP-1 drug

Eli Lilly targets alleged black market sales of its experimental GLP-1 drug

Eli Lilly is suing six entitles that it alleges are selling black market versions of its experimental weight loss drug retatrutide.  Lilly’s lawsuits target U.S. entities selling illegal retatrutide products, including compounding pharmacies, medical spas and online sellers that sell retatrutide as a weight-loss “hack.”  Those entities falsely claim their drugs are for “research-use only”…​  

You don't have permission to register